| The role of glutaminase in cancer BK Masisi, R El Ansari, L Alfarsi, EA Rakha, AR Green, ML Craze Histopathology 76 (4), 498-508, 2020 | 147 | 2020 |
| CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy LH Alfarsi, RE Ansari, ML Craze, MS Toss, B Masisi, IO Ellis, EA Rakha, ... Breast cancer research and treatment 178, 535-544, 2019 | 45 | 2019 |
| Glutamate dehydrogenase (GLUD1) expression in breast cancer ML Craze, R El-Ansari, MA Aleskandarany, KW Cheng, L Alfarsi, B Masisi, ... Breast cancer research and treatment 174, 79-91, 2019 | 45 | 2019 |
| Co-expression effect of SLC7A5/SLC3A2 to predict response to endocrine therapy in oestrogen-receptor-positive breast cancer LH Alfarsi, R El-Ansari, ML Craze, BK Masisi, OJ Mohammed, IO Ellis, ... International Journal of Molecular Sciences 21 (4), 1407, 2020 | 31 | 2020 |
| PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer LH Alfarsi, R El Ansari, ML Craze, BK Masisi, IO Ellis, EA Rakha, ... BMC cancer 20, 1-8, 2020 | 19 | 2020 |
| The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer R El Ansari, L Alfarsi, ML Craze, BK Masisi, IO Ellis, EA Rakha, AR Green Breast Cancer Research and Treatment 181, 1-12, 2020 | 18 | 2020 |
| The biological and clinical significance of glutaminase in luminal breast cancer BK Masisi, R El Ansari, L Alfarsi, ML Craze, N Jewa, A Oldfield, H Cheung, ... Cancers 13 (16), 3963, 2021 | 16 | 2021 |
| SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer LH Alfarsi, R El Ansari, ML Craze, OJ Mohammed, BK Masisi, IO Ellis, ... Breast cancer research and treatment 189, 317-331, 2021 | 11 | 2021 |
| The amino acid transporter SLC7A11 expression in breast cancer P Nath, LH Alfarsi, R El-Ansari, BK Masisi, B Erkan, A Fakroun, IO Ellis, ... Cancer Biology & Therapy 25 (1), 2291855, 2024 | 7 | 2024 |
| Integrated analysis of key differentially expressed genes identifies DBN1 as a predictive marker of response to endocrine therapy in luminal breast cancer LH Alfarsi, R El Ansari, BK Masisi, R Parks, OJ Mohammed, IO Ellis, ... Cancers 12 (6), 1549, 2020 | 7 | 2020 |
| ATF4 as a Prognostic Marker and Modulator of Glutamine Metabolism in Estrogen Receptor Positive Breast Cancer R Patel, LH Alfarsi, R El-Ansari, BK Masisi, B Erkan, A Fakroun, IO Ellis, ... Pathobiology: journal of immunopathology, molecular and cellular biology, 2023 | 1 | 2023 |
| Tripartite Motif-Containing 2, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Triple-Negative Breast Cancer Treated with Chemotherapy BK Masisi, R El Ansari, L Alfarsi, A Fakroun, B Erkan, A Ibrahim, M Toss, ... Cancers 16 (11), 1949, 2024 | | 2024 |
| 17P Tripartite motif containing 2: S glutamine metabolism-associated protein, predicts poor patient outcome in triple-negative breast cancer treated with chemotherapy BK Masisi ESMO Open 9, 2024 | | 2024 |
| Glutaminase 2 is associated with high glutaminolytic markers in breast cancer BK Masisi, REL Ansari, L Alfarsi, ML Craze, CC Nolan, EA Rakha, ... BREAST CANCER RESEARCH AND TREATMENT 180 (2), 550-550, 2020 | | 2020 |
| SLC1A5 interacts with TALDO1 to modulate metabolic pathway leading to endocrine resistance in oestrogen receptor-positive breast cancer LH Alfarsi, R El Ansari, M Craze, BK Masisi, IO Ellis, EA Rakha, AR Green BREAST CANCER RESEARCH AND TREATMENT 180 (2), 545-545, 2020 | | 2020 |
| Additional file 2 of PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer LH Alfarsi, R El Ansari, ML Craze, BK Masisi, IO Ellis, EA Rakha, ... Figshare, 2020 | | 2020 |
| High SLC1A5 Expression Predicts Resistance to Endocrine Therapy in ER plus Breast Cancer via Interacting with Metabolic Pathway L Alfarsi, R El Ansaria, C Craze, B Masisi, H Nicholls, I Ellis, A Rakha, ... JOURNAL OF PATHOLOGY 249, S25-S25, 2019 | | 2019 |
| Glutaminase Expression Predicts Recurrence in Ductal Carcinoma In Situ ML Craze, A Oldfield, M Toss, BK Masisi, R El Ansari, L Alfarsi, I Miligy, ... JOURNAL OF PATHOLOGY 249, S24-S24, 2019 | | 2019 |
